Insmed Financials - Benzinga

Insmed Inc

INSMNASDAQ

Trade with Public

Trade with Public

$115.63

近くで: Sep 30, 5:00 PM EST

$116.06

0.430.37%

時間外: 6:18 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Insmed Financials

Insmed (INSM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.73) by 91.78 percent. This is a 96.47 percent increase over losses of $(1.70) per share from the same

Benzinga Newsdesk

PRO
Insmed Raises FY2026 Sales Guidance from $1.450B-$1.470B to $1.700B-$1.870B vs $1.705B Est

Insmed (NASDAQ:INSM) raises FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.700 billion-$1.870 billion vs $1.705 billion estimate.

Benzinga Newsdesk

Nasdaq 100 Climbs Records, Oil Extends Drop As Iran Weighs Hormuz Deal: Stock Market Today

U.S. stocks drifted near records Thursday as oil slipped on Iran-Hormuz peace hopes. Coinbase, Airbnb and CoreWeave on deck after the close.

Piero Cingari

PRO
Insmed Affirms FY2026 Sales Guidance of $1.450B-$1.470B vs $1.699B Est

Insmed (NASDAQ:INSM) affirms FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.450 billion-$1.470 billion vs $1.699 billion estimate.

Benzinga Newsdesk

PRO
Insmed Q1 EPS $(0.76) Beats $(0.97) Estimate, Sales $305.964M Beat $303.298M Estimate

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.97) by 21.65 percent. This is a 46.48 percent increase over losses of $(1.42) per share from the same

Benzinga Newsdesk

PRO
CORRECTION: Insmed Sees FY2026 Sales $1.450B-$1.470B vs $1.372B Est

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved